Literature DB >> 28229158

Detection of procoagulant imbalance. Modified endogenous thrombin potential with results expressed as ratio of values with-to-without thrombomodulin.

Armando Tripodi1.   

Abstract

Each individual possesses his/her own endogenous-thrombin-potential (ETP) (i. e. the ability to generate thrombin) which depends on the relative strength of the pro- and anticoagulant drivers operating in plasma. This ability depends in turn on the clinical conditions in which the balance between the two drivers is variably affected. One of the major determinants of this balance is the factor (F)VIII-protein C(PC) axis and its effect can be conveniently explored by the thrombin generation procedures with results expressed as ETP ratio with/without thrombomodulin (TM) (ETP-TM ratio). Furthermore, owing to the many feedback mechanisms mediated by thrombin (e. g. activation of PC, FXI, FV, FVIII, platelets etc.) it is also possible that any perturbation of the balance between pro- and anticoagulants that may occur in plasma even outside the FVIII-PC axis could result in an increased ETP-TM ratio and therefore may suggest a procoagulant imbalance. Indeed, other non-coagulation moieties (e. g. microparticles, neutrophil extracellular traps, pro-inflammatory cytokines and others) circulating in blood of patients with various clinical conditions may also contribute to the procoagulant imbalance even when FVIII and/or PC are apparently normal. It can be postulated that dual ETP measurements performed in the presence and absence of TM with results expressed as their ratio may be the candidate procedure to detect subtle procoagulant imbalance in many clinical conditions characterised by an increased risk of thromboembolism. This article aimed at reviewing the clinical conditions in which evidence for the value of the ETP-TM ratio has been provided.

Entities:  

Keywords:  Hypercoagulability; factor VIII; protein C/S pathway; thrombosis

Mesh:

Substances:

Year:  2017        PMID: 28229158     DOI: 10.1160/TH16-10-0806

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism.

Authors:  Magnus S Edvardsen; Kristian Hindberg; Ellen-Sofie Hansen; Vânia M Morelli; Thor Ueland; Pål Aukrust; Sigrid K Brækkan; Line H Evensen; John-Bjarne Hansen
Journal:  Blood Adv       Date:  2021-01-12

Review 2.  Hypercoagulability in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): Causes and Consequences.

Authors:  Armando Tripodi; Rosa Lombardi; Massimo Primignani; Vincenzo La Mura; Flora Peyvandi; Anna L Fracanzani
Journal:  Biomedicines       Date:  2022-01-24

3.  Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo-coagulable and Hyper-coagulable Features.

Authors:  Alberto Zanetto; Henry M Rinder; Elena Campello; Graziella Saggiorato; Yanhong Deng; Maria Ciarleglio; Francis P Wilson; Marco Senzolo; Sabrina Gavasso; Cristiana Bulato; Paolo Simioni; Guadalupe Garcia-Tsao
Journal:  Hepatology       Date:  2020-10       Impact factor: 17.425

4.  Gender-specific differences in haemostatic parameters and their influence on blood loss in bimaxillary surgery.

Authors:  Michael Schwaiger; Sarah-Jayne Edmondson; Jasmin Rabensteiner; Florian Prüller; Thomas Gary; Wolfgang Zemann; Jürgen Wallner
Journal:  Clin Oral Investig       Date:  2022-01-11       Impact factor: 3.573

5.  Is There Any Improvement of the Coagulation Imbalance in Sickle Cell Disease after Hematopoietic Stem Cell Transplantation?

Authors:  Laurence Rozen; Denis F Noubouossie; Laurence Dedeken; Phu Quoc Lê; Alina Ferster; Anne Demulder
Journal:  J Clin Med       Date:  2019-10-26       Impact factor: 4.241

6.  Procoagulant Imbalance in Klinefelter Syndrome Assessed by Thrombin Generation Assay and Whole-Blood Thromboelastometry.

Authors:  Rita Indirli; Emanuele Ferrante; Erica Scalambrino; Eriselda Profka; Marigrazia Clerici; Tommaso Lettera; Andreea Liliana Serban; Walter Vena; Alessandro Pizzocaro; Marco Bonomi; Biagio Cangiano; Giulia Carosi; Gherardo Mazziotti; Luca Persani; Andrea Lania; Maura Arosio; Flora Peyvandi; Giovanna Mantovani; Armando Tripodi
Journal:  J Clin Endocrinol Metab       Date:  2021-03-25       Impact factor: 5.958

7.  Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia.

Authors:  Sara Bonato; Andrea Artoni; Anna Lecchi; Ghil Schwarz; Silvia La Marca; Lidia Padovan; Marigrazia Clerici; Chiara Guadino; Giacomo Pietro Comi; Armando Tripodi; Flora Peyvandi
Journal:  Haematologica       Date:  2021-11-01       Impact factor: 9.941

8.  Evaluation of procoagulant imbalance in Cushing's syndrome after short- and long-term remission of disease.

Authors:  E Ferrante; A L Serban; M Clerici; R Indirli; E Scalambrino; G Carosi; L Padovan; M Locatelli; M Arosio; F Peyvandi; G Mantovani; A Tripodi
Journal:  J Endocrinol Invest       Date:  2021-06-11       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.